{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:01:52Z","timestamp":1789999312514,"version":"4.0.1"},"reference-count":121,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: Radiotherapy and docetaxel are mainstays of prostate cancer management, yet both are constrained-radiotherapy by normal-tissue tolerance and docetaxel by systemic toxicity and acquired resistance. Ultrasound-activated microbubbles (USMB) convert acoustic energy into spatially localized mechanical bioeffects that can potentiate both. This review examines USMB as a precision chemo- and radio-enhancer in prostate cancer. Methods: We conducted a scoping review with mechanistic and translational synthesis, informed by PRISMA-ScR reporting principles. We identified sources through a structured bibliographic search and supported it with source-level verification. Heterogeneity in model systems, acoustic parameters, treatment regimens, and outcomes precluded meaningful quantitative pooling; we therefore synthesized the evidence narratively. Results: Two distinct mechanisms recur: sonoporation-cavitation-driven permeabilization that increases intracellular docetaxel delivery and acid sphingomyelinase (ASMase)-mediated ceramide-driven endothelial perturbation that sensitizes tumor vasculature to radiation. In prostate models, the three modalities enhance one another, and the triple combination produces the largest reported increases in clonogenic death, apoptosis, and regression in selected immunodeficient PC3 models. These effects were achieved at reduced experimental drug and radiation doses, a potential dose-sparing benefit that remains a preclinical hypothesis. Human data, although still outside the prostate, provide early support for feasibility and acceptable safety in selected USMB-enhanced settings. Conclusions: The rationale is coherent and the preclinical prostate signal consistent, but the evidence remains predominantly preclinical, PC3-dominated, and heterogeneous. USMB is best understood not as a drug-delivery technique but as a tunable sensitization platform whose outcome depends on acoustic dose, vascular state, and sequencing; parameter standardization, prostate-specific delivery, and cautious early-phase trials remain prerequisites for translation.<\/jats:p>","DOI":"10.3390\/cancers18183067","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:50:03Z","timestamp":1789995003000},"page":"3067","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ultrasound-Activated Microbubbles for Precision Chemo-Radioenhancement in Prostate Cancer: Sonoporation, Therapeutic Synergy, and Translational Pathways"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1798-378X","authenticated-orcid":false,"given":"Firas","family":"Almasri","sequence":"first","affiliation":[{"name":"College of Engineering and Sciences, International University of Science and Technology in Kuwait, Ardiya 92400, Kuwait"},{"name":"Center for Education Studies, University of Warwick, Coventry CV4 7AL, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9589-9041","authenticated-orcid":false,"given":"Raffi","family":"Karshafian","sequence":"additional","affiliation":[{"name":"Department of Physics, Toronto Metropolitan University, Toronto, ON M5B 2K3, Canada"},{"name":"Institute for Biomedical Engineering, Science and Technology (iBEST), a Partnership Between Toronto Metropolitan University and St. Michael\u2019s Hospital, Toronto, ON M5B 1T8, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41585-020-0310-3","article-title":"Harnessing the potential of multimodal radiotherapy in prostate cancer","volume":"17","author":"Philippou","year":"2020","journal-title":"Nat. Rev. Urol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.euf.2023.03.020","article-title":"Late Toxicities of Prostate Radiotherapy: Can We Further SMARTen Up the Therapeutic Index?","volume":"9","author":"Safavi","year":"2023","journal-title":"Eur. Urol. Focus"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur. Urol."},{"key":"ref_4","first-page":"CD012817","article-title":"Dose-escalated radiotherapy for clinically localized and locally advanced prostate cancer","volume":"2023","author":"Kim","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12943-023-01801-2","article-title":"Molecular mechanisms of tumor resistance to radiotherapy","volume":"22","author":"Wu","year":"2023","journal-title":"Mol. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"112367","DOI":"10.1016\/j.cellsig.2026.112367","article-title":"Cellular signaling and radioresistance in prostate cancer","volume":"141","author":"Sosa","year":"2026","journal-title":"Cell. Signal."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/MOU.0000000000001292","article-title":"Biochemical recurrence after radical prostatectomy and postoperative radiotherapy: Current evidence and controversial issues","volume":"35","author":"Longoni","year":"2025","journal-title":"Curr. Opin. Urol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.21037\/tcr-24-245","article-title":"Management strategies for radio-recurrent prostate cancer: A comprehensive review","volume":"13","author":"Rahman","year":"2024","journal-title":"Transl. Cancer Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"177149","DOI":"10.1016\/j.ejphar.2024.177149","article-title":"Targets for improving prostate tumor response to radiotherapy","volume":"986","author":"Li","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"218183","DOI":"10.1016\/j.canlet.2025.218183","article-title":"Overcoming radioresistance in prostate cancer by targeting DNA damage repair","volume":"639","author":"Matos","year":"2026","journal-title":"Cancer Lett."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1056\/NEJMoa040720","article-title":"Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer","volume":"351","author":"Tannock","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1200\/JCO.2007.12.4008","article-title":"Docetaxel Plus Prednisone or Mitoxantrone Plus Prednisone for Advanced Prostate Cancer: Updated Survival in the TAX 327 Study","volume":"26","author":"Berthold","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1056\/NEJMoa1503747","article-title":"Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer","volume":"373","author":"Sweeney","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(15)01037-5","article-title":"Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): Survival results from an adaptive, multiarm, multistage, platform randomised controlled trial","volume":"387","author":"James","year":"2016","journal-title":"Lancet"},{"key":"ref_15","first-page":"676","article-title":"Molecular mechanisms of docetaxel resistance in prostate cancer","volume":"3","author":"Sekino","year":"2020","journal-title":"Cancer Drug Resist."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/MOU.0000000000001296","article-title":"Toxicities of taxane-based chemotherapy in prostate cancer","volume":"35","author":"Matsukawa","year":"2025","journal-title":"Curr. Opin. Urol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Linke, D., Donix, L., Peitzsch, C., Erb, H.H.H., Dubrovska, A., Pfeifer, M., Thomas, C., Fuessel, S., and Erdmann, K. (2022). Comprehensive Evaluation of Multiple Approaches Targeting ABCB1 to Resensitize Docetaxel-Resistant Prostate Cancer Cell Lines. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24010666"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Xing, S., Xu, Z., Zeng, S., Yue, M., Xing, W., and Liu, Q. (2026). RIPK2 induces docetaxel resistance in prostate cancer through the NF-kB\/P-gp signaling pathway. PLoS ONE, 21.","DOI":"10.1371\/journal.pone.0341445"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/cas.16040","article-title":"NOTCH3 promotes docetaxel resistance of prostate cancer cells through regulating TUBB3 and MAPK signaling pathway","volume":"115","author":"Sun","year":"2024","journal-title":"Cancer Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"188481","DOI":"10.1016\/j.bbcan.2020.188481","article-title":"Mechanisms of docetaxel resistance in prostate cancer: The key role played by miRNAs","volume":"1875","author":"Rizzo","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"769","DOI":"10.5534\/wjmh.220200","article-title":"Systemic Therapies for Metastatic Castration-Resistant Prostate Cancer: An Updated Review","volume":"41","author":"Hatano","year":"2023","journal-title":"World J. Men\u2019s Health"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s40487-025-00412-9","article-title":"Treatment Strategies in Metastatic Castration-Resistant Prostate Cancer: A Narrative Review of Considerations in the Post-ARTA, Post-Docetaxel Setting","volume":"14","author":"Ng","year":"2026","journal-title":"Oncol. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.ultrasmedbio.2020.01.027","article-title":"Microbubble Agents: New Directions","volume":"46","author":"Stride","year":"2020","journal-title":"Ultrasound Med. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2014.03.003","article-title":"Acoustic behavior of microbubbles and implications for drug delivery","volume":"72","author":"Kooiman","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jconrel.2020.06.008","article-title":"Ultrasound and microbubble mediated therapeutic delivery: Underlying mechanisms and future outlook","volume":"326","author":"Chowdhury","year":"2020","journal-title":"J. Control. Release"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"E2033","DOI":"10.1073\/pnas.1200053109","article-title":"Tumor radiation response enhancement by acoustical stimulation of the vasculature","volume":"109","author":"Czarnota","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1080\/10717544.2022.2110998","article-title":"Prostate-specific membrane antigen targeted, glutathione-sensitive nanoparticles loaded with docetaxel and enzalutamide for the delivery to prostate cancer","volume":"29","author":"Chen","year":"2022","journal-title":"Drug Deliv."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.2174\/0109298673337725250108091641","article-title":"Research Progress on the Application of Ultrasound Assistance in Tumor Immunotherapy","volume":"33","author":"Fan","year":"2026","journal-title":"Curr. Med. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2024.08.039","article-title":"The advance of ultrasound-enabled diagnostics and therapeutics","volume":"375","author":"Han","year":"2024","journal-title":"J. Control. Release"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Hooijmans, C.R., Rovers, M.M., de Vries, R.B.M., Leenaars, M., Ritskes-Hoitinga, M., and Langendam, M.W. (2014). SYRCLE\u2019s risk of bias tool for animal studies. BMC Med. Res. Methodol., 14.","DOI":"10.1186\/1471-2288-14-43"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ultras.2009.10.002","article-title":"Cavitation microstreaming and stress fields created by microbubbles","volume":"50","author":"Collis","year":"2010","journal-title":"Ultrasonics"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nphys148","article-title":"Membrane disruption by optically controlled microbubble cavitation","volume":"1","author":"Prentice","year":"2005","journal-title":"Nat. Phys."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"9983","DOI":"10.1073\/pnas.1606915113","article-title":"Biophysical insight into mechanisms of sonoporation","volume":"113","author":"Helfield","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4866","DOI":"10.1016\/j.bpj.2009.02.072","article-title":"Sonoporation by Single-Shot Pulsed Ultrasound with Microbubbles Adjacent to Cells","volume":"96","author":"Kudo","year":"2009","journal-title":"Biophys. J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nature01613","article-title":"Controlled vesicle deformation and lysis by single oscillating bubbles","volume":"423","author":"Marmottant","year":"2003","journal-title":"Nature"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"314","DOI":"10.7150\/thno.19010","article-title":"Tumor Vascular Shutdown and Cell Death Following Ultrasound-Microbubble Enhanced Radiation Therapy","volume":"8","author":"Gangeh","year":"2018","journal-title":"Theranostics"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jconrel.2005.01.007","article-title":"Plasma membrane poration induced by ultrasound exposure: Implication for drug delivery","volume":"104","author":"Bettinger","year":"2005","journal-title":"J. Control. Release"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ultrasmedbio.2004.01.005","article-title":"Ultrasound-induced cell membrane porosity","volume":"30","author":"Deng","year":"2004","journal-title":"Ultrasound Med. Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jconrel.2020.03.038","article-title":"Opening of endothelial cell-cell contacts due to sonoporation","volume":"322","author":"Beekers","year":"2020","journal-title":"J. Control. Release"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jconrel.2014.10.031","article-title":"Ultrasound and microbubble mediated drug delivery: Acoustic pressure as determinant for uptake via membrane pores or endocytosis","volume":"197","author":"Zagato","year":"2015","journal-title":"J. Control. Release"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/CIRCRESAHA.108.183806","article-title":"Ultrasound and Microbubble-Targeted Delivery of Macromolecules Is Regulated by Induction of Endocytosis and Pore Formation","volume":"104","author":"Meijering","year":"2009","journal-title":"Circ. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1080\/17425247.2018.1547279","article-title":"Sonopermeation to improve drug delivery to tumors: From fundamental understanding to clinical translation","volume":"15","author":"Snipstad","year":"2018","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"9807347","DOI":"10.34133\/2022\/9807347","article-title":"Ultrasound-Mediated Drug Delivery: Sonoporation Mechanisms, Biophysics, and Critical Factors","volume":"2022","author":"Tu","year":"2022","journal-title":"BME Front."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"115199","DOI":"10.1016\/j.addr.2024.115199","article-title":"From concept to early clinical trials: 30 years of microbubble-based ultrasound-mediated drug delivery research","volume":"206","author":"Bouakaz","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.1038\/s41598-021-84341-3","article-title":"Sonoporation generates downstream cellular impact after membrane resealing","volume":"11","author":"Duan","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00232-015-9834-5","article-title":"The Roles of Tight Junctions and Claudin-1 in the Microbubble-Mediated Ultrasound-Induced Enhancement of Drug Concentrations in Rat Prostate","volume":"248","author":"Shang","year":"2015","journal-title":"J. Membr. Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s12013-012-9383-9","article-title":"Mechanisms of Prostate Permeability Triggered by Microbubble-Mediated Acoustic Cavitation","volume":"64","author":"Li","year":"2012","journal-title":"Cell Biochem. Biophys."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Karshafian, R., Almasri, F., Giles, A., and Czarnota, G.J. (2010, January 11\u201314). Enhancing chemotherapy by ultrasound and microbubbles: Effect of acoustic pressure and treatment order in in vitro suspension of breast and prostate cancer cells. Proceedings of the 2010 IEEE International Ultrasonics Symposium, San Diego, CA, USA.","DOI":"10.1109\/ULTSYM.2010.5935914"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Goertz, D.E., Todorova, M., Mortazavi, O., Agache, V., Chen, B., Karshafian, R., and Hynynen, K. (2012). Antitumor Effects of Combining Docetaxel (Taxotere) with the Antivascular Action of Ultrasound Stimulated Microbubbles. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0052307"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11307-013-0672-5","article-title":"Sonoporation-Enhanced Chemotherapy Significantly Reduces Primary Tumor Burden in an Orthotopic Pancreatic Cancer Xenograft","volume":"16","author":"Kotopoulis","year":"2014","journal-title":"Mol. Imaging Biol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1080\/10717544.2022.2115163","article-title":"Optimal treatment occasion for ultrasound stimulated microbubbles in promoting gemcitabine delivery to VX2 tumors","volume":"29","author":"Luo","year":"2022","journal-title":"Drug Deliv."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3348\/kjr.2016.17.4.497","article-title":"Ultrasound-Guided Delivery of siRNA and a Chemotherapeutic Drug by Using Microbubble Complexes: In Vitro and In Vivo Evaluations in a Prostate Cancer Model","volume":"17","author":"Bae","year":"2016","journal-title":"Korean J. Radiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.2147\/IJN.S136032","article-title":"Paclitaxel-loaded and A10-3.2 aptamer-targeted poly(lactide-co-glycolic acid) nanobubbles for ultrasound imaging and therapy of prostate cancer","volume":"12","author":"Wu","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.2147\/IJN.S111808","article-title":"Inhibition of prostate cancer growth using doxorubicin assisted by ultrasound-targeted nanobubble destruction","volume":"11","author":"Fan","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3892\/ol.2015.3946","article-title":"Upregulation of ULK1 expression in PC-3 cells following tumor protein P53 transfection by sonoporation","volume":"11","author":"Wang","year":"2015","journal-title":"Oncol. Lett."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Wang, L., Zhang, M., Tan, K., Guo, Y., Tong, H., Fan, X., Fang, K., and Li, R. (2014). Preparation of Nanobubbles Carrying Androgen Receptor siRNA and Their Inhibitory Effects on Androgen-Independent Prostate Cancer when Combined with Ultrasonic Irradiation. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0096586"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/17425247.2022.2061459","article-title":"Delivery of anti-cancer drugs using microbubble-assisted ultrasound in digestive oncology: From preclinical to clinical studies","volume":"19","author":"Escoffre","year":"2022","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.2217\/fon.15.19","article-title":"Biomechanical Effects of Microbubbles: From Radiosensitization to Cell Death","volume":"11","author":"Czarnota","year":"2015","journal-title":"Future Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.ultrasmedbio.2012.07.009","article-title":"Bioeffects of Ultrasound-Stimulated Microbubbles on Endothelial Cells: Gene Expression Changes Associated with Radiation Enhancement In Vitro","volume":"38","author":"Karshafian","year":"2012","journal-title":"Ultrasound Med. Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/jnci\/djy011","article-title":"Role of Acid Sphingomyelinase and Ceramide in Mechano-Acoustic Enhancement of Tumor Radiation Responses","volume":"110","author":"Hashim","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"dmm049531","DOI":"10.1242\/dmm.049531","article-title":"Ultrasound-stimulated microbubbles enhanced vascular disruption in fractionated radiotherapy-treated tumor s via ASMase activation","volume":"16","author":"Leong","year":"2023","journal-title":"Dis. Model. Mech."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"944","DOI":"10.18632\/oncoscience.277","article-title":"Ultrasound-stimulated microbubble enhancement of radiation treatments: Endothelial cell function and mechanism","volume":"2","author":"Wong","year":"2015","journal-title":"Oncoscience"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Al-Mahrouki, A., Giles, A., Hashim, A., Kim, H.C., El-Falou, A., Rowe-Magnus, D., Farhat, G., and Czarnota, G.J. (2017). Microbubble-based enhancement of radiation effect: Role of cell membrane ceramide metabolism. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0181951"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Sharma, D., McNabb, E., Law, N., Cumal, A., and Czarnota, G.J. (2023). Ultrasound-stimulated microbubbles enhancement of fractionated radiation for tumor treatment. BMC Cancer, 23.","DOI":"10.1186\/s12885-023-10981-5"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"McNabb, E., Al-Mahrouki, A., Law, N., McKay, S., Tarapacki, C., Hussein, F., and Czarnota, G.J. (2020). Ultrasound-stimulated microbubble radiation enhancement of tumors: Single-dose and fractionated treatment evaluation. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0239456"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"15330338221132925","DOI":"10.1177\/15330338221132925","article-title":"Focused Ultrasound Stimulation of Microbubbles in Combination With Radiotherapy for Acute Damage of Breast Cancer Xenograft Model","volume":"21","author":"Sharma","year":"2022","journal-title":"Technol. Cancer Res. Treat."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1159\/000492263","article-title":"Ultrasound-Stimulated Microbubbles Enhance Radiosensitization of Nasopharyngeal Carcinoma","volume":"48","author":"Deng","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1139\/bcb-2021-0061","article-title":"Ultrasound-stimulated microbubbles contributes to radiotherapy in esophageal carcinoma","volume":"99","author":"Fu","year":"2021","journal-title":"Biochem. Cell Biol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"4487","DOI":"10.1038\/s41598-023-30286-8","article-title":"MR-guided ultrasound-stimulated microbubble therapy enhances radiation-induced tumor response","volume":"13","author":"McNabb","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1021\/acs.bioconjchem.1c00510","article-title":"Targeted Anti-Cancer Provascular Therapy Using Ultrasound, Microbubbles, and Nitrite to Increase Radiotherapy Efficacy","volume":"33","author":"Michon","year":"2022","journal-title":"Bioconjug. Chem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1158\/1078-0432.CCR-11-2711","article-title":"Tumor Hypoxia Predicts Biochemical Failure following Radiotherapy for Clinically Localized Prostate Cancer","volume":"18","author":"Milosevic","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1080\/09553002.2025.2498980","article-title":"Radiotherapeutic enhancement using ultrasound-stimulated microbubbles: A critical review","volume":"101","author":"Box","year":"2025","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.zemedi.2023.04.007","article-title":"Radiation combined with ultrasound and microbubbles: A potential novel strategy for cancer treatment","volume":"33","author":"Sharma","year":"2023","journal-title":"Z. Med. Phys."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(19)31131-6","article-title":"Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial","volume":"394","author":"Widmark","year":"2019","journal-title":"Lancet"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Rakotomalala, A., Escande, A., Furlan, A., Meignan, S., and Lartigau, E. (2021). Hypoxia in Solid Tumors: How Low Oxygenation Impacts the Six Rs of Radiotherapy. Front. Endocrinol., 12.","DOI":"10.3389\/fendo.2021.742215"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"105312","DOI":"10.1016\/j.jddst.2023.105312","article-title":"Progress and preclinical application status of ultrasound microbubbles","volume":"92","author":"Hu","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1007\/s11434-013-5753-y","article-title":"Treatment of PC-3 cells with ultrasound combined with microbubbles induces distinct alterations in the expression of Bcl-2 and Bax","volume":"58","author":"Bai","year":"2013","journal-title":"Chin. Sci. Bull."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Chen, L., Liu, J., Chen, Q., Li, Y., He, Y., Jin, H., Qiu, D., Feng, Y., Xi, F., and Ma, S. (2025). Modulating tumor interstitial fluid pressure using ultrasound and microbubble therapy: A preclinical study for enhanced drug delivery in cancer treatment. BMC Cancer, 26.","DOI":"10.1186\/s12885-025-15218-1"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.canlet.2020.10.046","article-title":"Tumor perfusion enhancement by ultrasound stimulated microbubbles potentiates PD-L1 blockade of MC38 colon cancer in mice","volume":"498","author":"Li","year":"2021","journal-title":"Cancer Lett."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e10213","DOI":"10.1016\/j.heliyon.2022.e10213","article-title":"Synergistic enhancement of cell death by triple combination therapy of docetaxel, ultrasound and microbubbles, and radiotherapy on PC3 a prostate cancer cell line","volume":"8","author":"Almasri","year":"2022","journal-title":"Heliyon"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Almasri, F., Sakarya, E.H., and Karshafian, R. (2023). Radioenhancement with the Combination of Docetaxel and Ultrasound Microbubbles: In Vivo Prostate Cancer. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15051468"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1088\/0031-9155\/57\/2\/535","article-title":"MR-guided pulsed high intensity focused ultrasound enhancement of docetaxel combined with radiotherapy for prostate cancer treatment","volume":"57","author":"Mu","year":"2012","journal-title":"Phys. Med. Biol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1080\/09553002.2023.2263553","article-title":"Docetaxel radiosensitizes castration-resistant prostate cancer by downregulating CAV-1","volume":"100","author":"Tu","year":"2024","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.ultrasmedbio.2008.10.013","article-title":"Sonoporation by Ultrasound-Activated Microbubble Contrast Agents: Effect of Acoustic Exposure Parameters on Cell Membrane Permeability and Cell Viability","volume":"35","author":"Karshafian","year":"2009","journal-title":"Ultrasound Med. Biol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jconrel.2016.07.037","article-title":"Viability of endothelial cells after ultrasound-mediated sonoporation: Influence of targeting, oscillation, and displacement of microbubbles","volume":"238","author":"Skachkov","year":"2016","journal-title":"J. Control. Release"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.ultrasmedbio.2013.01.012","article-title":"Effects of Biophysical Parameters in Enhancing Radiation Responses of Prostate Tumors with Ultrasound-Stimulated Microbubbles","volume":"39","author":"Kim","year":"2013","journal-title":"Ultrasound Med. Biol."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Kotopoulis, S., Popa, M., Safont, M.M., Murvold, E., Haugse, R., Langer, A., Dimcevski, G., Lam, C., Bjanes, T., and Gilja, O.H. (2022). SonoVue vs. Sonazoid vs. Optison: Which Bubble Is Best for Low-Intensity Sonoporation of Pancreatic Ductal Adenocarcinoma?. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14010098"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3390\/radiation3030013","article-title":"In Vitro Radioenhancement Using Ultrasound-Stimulated Microbubbles: A Comparison of Suspension and Adherent Cell States","volume":"3","author":"McCorkell","year":"2023","journal-title":"Radiation"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1002\/jum.15363","article-title":"Effect of Treatment Sequencing on the Tumor Response to Combined Treatment With Ultrasound-Stimulated Microbubbles and Radiotherapy","volume":"39","author":"Klein","year":"2020","journal-title":"J. Ultrasound Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.3892\/ol.2014.2310","article-title":"Combined treatment of PC-3 cells with ultrasound and microbubbles suppresses invasion and migration","volume":"8","author":"Wei","year":"2014","journal-title":"Oncol. Lett."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Kim, H.C., Al-Mahrouki, A., Gorjizadeh, A., Sadeghi-Naini, A., Karshafian, R., and Czarnota, G.J. (2014). Quantitative Ultrasound Characterization of Tumor Cell Death: Ultrasound-Stimulated Microbubbles for Radiation Enhancement. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0102343"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.ultrasmedbio.2012.01.028","article-title":"Quantitative Ultrasound for the Monitoring of Novel Microbubble and Ultrasound Radiosensitization","volume":"38","author":"Lee","year":"2012","journal-title":"Ultrasound Med. Biol."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Sharma, D., Osapoetra, L.O., Faltyn, M., Giles, A., Stanisz, M., and Czarnota, G.J. (2021). In vivo assessment of prostate cancer response using quantitative ultrasound characterization of ultrasonic scattering properties. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-08706-7"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Zhou, B., Lian, Q., Jin, C., Lu, J., Xu, L., Gong, X., and Zhou, P. (2022). Human clinical trial using diagnostic ultrasound and microbubbles to enhance neoadjuvant chemotherapy in HER2-negative breast cancer. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.992774"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"102213","DOI":"10.1016\/j.nano.2020.102213","article-title":"Real time ultrasound molecular imaging of prostate cancer with PSMA-targeted nanobubbles","volume":"28","author":"Perera","year":"2020","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00345-012-0833-1","article-title":"Usefulness of perflubutane microbubble-enhanced ultrasound in imaging and detection of prostate cancer: Phase II multicenter clinical trial","volume":"31","author":"Uemura","year":"2013","journal-title":"World J. Urol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.7150\/thno.71221","article-title":"A theranostic 3D ultrasound imaging system for high resolution image-guided therapy","volume":"12","author":"Bendjador","year":"2022","journal-title":"Theranostics"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"e70068","DOI":"10.1002\/wnan.70068","article-title":"Development of Ultrasound Microbubbles and Phase Shift Microbubbles in Theranostics","volume":"18","author":"Meuillet","year":"2026","journal-title":"WIREs Nanomed. Nanobiotechnol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jconrel.2016.10.007","article-title":"A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer","volume":"243","author":"Dimcevski","year":"2016","journal-title":"J. Control. Release"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"072902","DOI":"10.1118\/1.4808149","article-title":"Treatment of human pancreatic cancer using combined ultrasound, microbubbles, and gemcitabine: A clinical case study","volume":"40","author":"Kotopoulis","year":"2013","journal-title":"Med. Phys."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Moore-Palhares, D., Dasgupta, A., Saifuddin, M., Anzola Pena, M.L., Prasla, S., Ho, L., Lu, L., Kung, J., McNabb, E., and Sannachi, L. (2024). Radiation enhancement using focussed ultrasound-stimulated microbubbles for breast cancer: A Phase 1 clinical trial. PLoS Med., 21.","DOI":"10.1371\/journal.pmed.1004408"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"13566","DOI":"10.1038\/s41598-023-40551-5","article-title":"Novel MRI-guided focussed ultrasound stimulated microbubble radiation enhancement treatment for breast cancer","volume":"13","author":"Dasgupta","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"110380","DOI":"10.1016\/j.radonc.2024.110380","article-title":"Radiation enhancement using focussed ultrasound-stimulated microbubbles for head and neck cancer: A phase 1 clinical trial","volume":"198","author":"Saifuddin","year":"2024","journal-title":"Radiother. Oncol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"e250083","DOI":"10.1148\/radiol.250083","article-title":"Microbubble-based Radiosensitization of Hepatocellular Carcinoma: Evaluation of Safety and Efficacy in a Phase II Randomized Trial","volume":"316","author":"Wessner","year":"2025","journal-title":"Radiology"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"100080","DOI":"10.1016\/j.wfumbo.2025.100080","article-title":"Treatment of inoperable pancreatic adenocarcinoma with focused ultrasound and microbubbles in patients receiving chemotherapy","volume":"3","author":"Haram","year":"2025","journal-title":"WFUMB Ultrasound Open"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1016\/j.ultrasmedbio.2021.07.003","article-title":"Safety of Image-Guided Treatment of the Liver with Ultrasound and Microbubbles in an in Vivo Porcine Model","volume":"47","author":"Keller","year":"2021","journal-title":"Ultrasound Med. Biol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"103149","DOI":"10.1016\/j.nantod.2026.103149","article-title":"From development to regulation: Translational pipeline results for molecularly targeted polymeric microbubbles","volume":"71","author":"Eckardt","year":"2026","journal-title":"Nano Today"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Yang, Y., Cheng, Y., Chen, Z., and Liu, Y. (2025). A Review on the Structure-Response-Efficacy Optimization of Ultrasound-Responsive Micro\/Nanobubbles for Cancer Therapy. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17111378"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"119243","DOI":"10.1016\/j.biopha.2026.119243","article-title":"Beyond total release: Fragment-resolved metrics for ultrasound microbubble-mediated drug delivery","volume":"198","author":"Lin","year":"2026","journal-title":"Biomed. Pharmacother."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"108199","DOI":"10.1016\/j.jddst.2026.108199","article-title":"Versatile potential of ultrasound mediated microbubble for biomedical applications: Current trends and emerging strategies","volume":"120","author":"Sarkar","year":"2026","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1055\/a-1177-0530","article-title":"Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver-Update 2020-WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS","volume":"41","author":"Dietrich","year":"2020","journal-title":"Ultraschall Med."},{"key":"ref_113","first-page":"a28990967","article-title":"Barriers to the Broader Use of Contrast-Enhanced Ultrasound in Saudi Healthcare and Medical Research","volume":"12","author":"Almushayt","year":"2026","journal-title":"Ultrasound Int. Open"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"de Maar, J.S., Rousou, C., van Elburg, B., Vos, H.J., Lajoinie, G.P.R., Bos, C., Moonen, C.T.W., and Deckers, R. (2021). Ultrasound-Mediated Drug Delivery With a Clinical Ultrasound System: In Vitro Evaluation. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.768436"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.canlet.2019.06.017","article-title":"Translational Prospects of ultrasound-mediated tumor immunotherapy: Preclinical advances and safety considerations","volume":"460","author":"Xu","year":"2019","journal-title":"Cancer Lett."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.fmre.2024.10.017","article-title":"Recent advances in ultrasound-targeted nanobubbles combined with cancer immunotherapy: Mechanisms, applications, and challenges","volume":"6","author":"Chen","year":"2026","journal-title":"Fundam. Res."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ultrasmedbio.2023.08.019","article-title":"A Review of Ultrasound-Mediated Checkpoint Inhibitor Immunotherapy","volume":"50","author":"Rivera","year":"2024","journal-title":"Ultrasound Med. Biol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12951-025-03959-x","article-title":"Ultrasound-responsive micro\/nanobubbles based intelligent theranostic systems for precision tumor therapy","volume":"24","author":"Liu","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"ref_119","first-page":"45","article-title":"Ultrasound-mediated drug-free theranostics for treatment of prostate cancer","volume":"35","author":"Perera","year":"2024","journal-title":"Bioact. Mater."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"629751","DOI":"10.2147\/IJN.S629751","article-title":"Nanotechnology in Prostate Cancer: PSMA-Targeted Nanoplatforms, TME-Responsive Therapy, Immunomodulation, and Clinical Translation Challenges","volume":"21","author":"Li","year":"2026","journal-title":"Int. J. Nanomed."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1200\/JCO.20.02873","article-title":"Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: Results From the FLAME Randomized Phase III Trial","volume":"39","author":"Kerkmeijer","year":"2021","journal-title":"J. Clin. Oncol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/18\/3067\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:16:36Z","timestamp":1789996596000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/18\/3067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":121,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["cancers18183067"],"URL":"https:\/\/doi.org\/10.3390\/cancers18183067","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]}}}